Why BGPT?
logo

Review papers with raw data transparency

Quickly verify claims by accessing the underlying experimental data and figures.







Press Enter ↡ to solve



    Fuel Your Discoveries




     Quick Explanation



    Core claim
    The paper argues that Akt2 binds the JNK scaffold POSH, and this binding negatively regulates assembly/activation of the POSH–MLK3–MKK4/7–JNK complex, in part by promoting MLK3 phosphorylation and complex disassembly, reducing JNK output (e.g., phospho-c-Jun).
    Skeptical takeaway
    The mechanistic link is plausible and supported by multiple perturbation types (binding-site mutants, PI3K/Akt inhibition, and dominant-interfering domains), but a key remaining gap is whether endogenous Akt2–POSH complexes dynamically regulate MLK3 phosphorylation and JNK flux in vivo at physiological stoichiometry (the work is largely overexpression/perturbation-based in cell lines and yeast).



     Long Explanation



    Paper Review (Full-Text Grounded): Akt2 Negatively Regulates Assembly of the POSH-MLK-JNK Signaling Complex
    Journal of Biological Chemistry β€’ DOI: 10.1074/jbc.M307357200
    Mechanistic model (as proposed by the authors)
    Interpretation of the paper’s working model: Akt2 binding to POSH suppresses formation/activation of the POSH–MLK3–MKK4/7–JNK scaffold module, increasing JNK-inhibitory outcomes via MLK3 phosphorylation-dependent complex disassembly, reducing downstream phospho-c-Jun signaling readouts.
    Note: This diagram is an interpretation of the authors’ model and assay readouts, not a quantified kinetic model.
    Evidence types used to support the central claim
    The paper builds a convergent case using at least four perturbation categories: (1) yeast two-hybrid interaction mapping, (2) mammalian co-association assays (GST pull-down/co-IP), (3) binding-site mutants (POSH W489A; POSH E470Q; Akt2 proline motif mutations), and (4) pathway/activity perturbations (PI3K/Akt inhibition with LY294002; dominant-interfering POSH Akt2-binding domain; JNK readouts via phospho-c-Jun and MLK3 Ser-674 phosphorylation).
    Central claims and how the paper supports them
    1) POSH binds Akt2 preferentially (not Akt1)
    • Yeast two-hybrid: POSH-(447–550), containing SH3-3, interacts with Akt2 deletion construct (⌬PH Akt2) but not Akt1 (and not Lamin control).
    • Mammalian co-association: GST-POSH-(447–550) pulls down full-length Akt2, with minimal/no detectable Akt1 under prolonged exposure in their described control context.
    • Co-localization: POSH and Akt2 co-localize in lamellipodia in COS cells under activated Rac context, with additional handling for POSH full-length expression toxicity (caspase inhibitor).
    2) The POSH–Akt2 interface maps to POSH SH3-3 residues and Akt2 proline-rich motifs
    • POSH SH3-3 key residues: Mutating Glu-470 (E470Q) and Trp-489 (W489A) markedly diminishes Akt2 binding in yeast two-hybrid and HEK293 pull-downs.
    • Akt2 uses two Pro-X-X-Pro motifs: The authors test proline motif mutants and conclude both sites contribute to binding, though mutating all four prolines does not fully abolish interaction (suggesting additional residues beyond the core motifs contribute to affinity).
    3) Akt2 binding to POSH suppresses POSH-dependent MLK3 binding and downstream JNK output
    • Akt2-binding-defective POSH (W489A) increases POSH–MLK3 association and increases phospho-c-Jun (JNK pathway activation readout).
    • PI3K/Akt inhibition (LY294002) increases MLK3 association with POSH, consistent with endogenous Akt activity normally restraining POSH–MLK3 complex assembly.
    • Dominant-interfering POSH fragment POSH-(447–550) behaves as a titration module for endogenous Akt2 and increases JNK output (phospho-c-Jun), while reducing Akt-phosphorylated MLK3 (Ser-674).
    Causal chain (as tested) vs. what remains inferred
    More direct evidence (tested)
    1. Binding: POSH SH3-3 ↔ Akt2 interaction is supported by yeast two-hybrid + GST pull-down/co-association.
    2. Assembly/activity readouts: POSH W489A and POSH-(447–550) perturb POSH–MLK3 association and phospho-c-Jun levels in ways consistent with reduced Akt2-mediated inhibition.
    3. Phosphorylation link: POSH-(447–550) reduces Akt-phosphorylated MLK3 at Ser-674.
    More inferential / not fully resolved
    • Physiological stoichiometry & dynamics: much of the evidence uses overexpression domains/mutants (and LY294002 inhibition) rather than direct endogenous complex quantification of dynamic turnover.
    • Mechanistic exclusivity: the model emphasizes Akt2-mediated MLK3 phosphorylation causing complex disassembly, but the paper does not fully exclude that Akt2 might also alter other steps in the module (e.g., MLK3 recruitment, MKK4/7 access, or scaffolding competition).
    Critical appraisal (skeptical review)
    Strengths
    • Multi-layer convergence: binding specificity (yeast + mammalian) converges with functional signaling readouts (phospho-c-Jun) and MLK3 phosphorylation status (Ser-674).
    • Use of binding-site mutants: POSH SH3-3 mutations and Akt2 proline motif mutations provide mechanistic specificity rather than relying solely on broad pharmacology.
    • Endogenous pathway perturbation: LY294002 is used to modulate endogenous PI3K/Akt signaling status, shifting the POSH–MLK3 association outcome.
    Potential blind spots / limitations
    • Overexpression / dominant fragments: many assays depend on transient transfection of tagged proteins or POSH fragments; this can shift local concentrations, introduce non-physiological competition, or alter subcellular distributions.
    • Readout specificity: phospho-c-Jun and MLK3 Ser-674 phosphorylation are appropriate pathway markers, but they do not directly measure scaffold disassembly kinetics or the occupancy of POSH with MLK3 vs. other competing partners under each perturbation.
    • Scope: the work maps isoform specificity to Akt2 vs Akt1 and proposes isoform-specific scaffold regulation, but it does not exhaustively characterize whether other scaffolds (e.g., JIP1) compensate in the same cellular contexts.
    Optional: run a fully independent Science Agent to deepen this review


    Feedback:   

    Updated: April 01, 2026

    BGPT Paper Review



    Study Novelty

    80%

    The paper provides a relatively early, mechanistically specific link between Akt2 and the POSH scaffold controlling JNK signaling output, including interface mapping and functional consequences across multiple perturbation types.



    Scientific Quality

    80%

    Scientifically rigorous within its scope: binding specificity is mapped, functional readouts align with the model, and multiple perturbation classes are used. Key limitations are physiological validation (mostly cell/overexpression based) and incomplete direct measurement of scaffold disassembly kinetics/occupancy in endogenous settings.



    Study Generality

    70%

    Mechanistic insight into isoform-specific cross-talk between PI3K/Akt and JNK via scaffolding is broadly informative for signaling networks, though the detailed interface and context (Akt2–POSH in HEK293/COS and yeast systems) may be cell-type dependent.



    Study Usefulness

    80%

    High utility for researchers studying scaffold-mediated signaling, Akt–JNK pathway cross-talk, and designing experiments that probe isoform-specific protein interactions using interface mutants and dominant-interfering domains.



    Study Reproducibility

    70%

    Methods are described at a level enabling replication (transfection, co-association assays, LY294002 pre-treatment, mutant construction strategies), but the paper does not clearly specify data availability/accessions and relies on transient systems where exact expression levels and reagent batches can affect outcomes.



    Explanatory Depth

    80%

    The paper offers a coherent mechanistic pathway: Akt2–POSH binding β†’ increased POSH–MLK3 association is controlled by Akt2; Akt2 activity correlates with reduced MLK3 phosphorylation at Ser-674 when Akt2 binding is sequestered; downstream JNK output follows. Remaining uncertainty is the precise causal mechanism of β€œdisassembly” at the single-molecule/occupancy level.


    🎁 Authors: Collect 401 Free Science Tokens (β‰ˆ $40.1 USD)

    Claim My Author Tokens

    Use for 100 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $40.1 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    Extract the POSH SH3-3 and Akt2 proline-motif regions stated in the paper, align SH3 ligand motifs across Akt isoforms, and generate a motif-annotation plot to rationalize binding specificity.



     Hypothesis Graveyard



    A β€œfully independent JNK inhibition” model where Akt2 phosphorylates downstream JNK components without affecting POSH–MLK3 complex assembly is less consistent with the observed changes in POSH–MLK3 co-association and phospho-c-Jun following Akt2-binding perturbations.


    An β€œAkt2-binding only affects localization of POSH, not functional assembly” explanation is weakened because the paper reports concomitant increases in MLK3 association with POSH and JNK output markers when Akt2 binding is disrupted or inhibited.

     Science Art


    Paper Review: Akt2 Negatively Regulates Assembly of the POSH-MLK-JNK Signaling Complex Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT